insured and uninsured populations. For the total U.S. adult population, 26.7% of health-care expenditures were associated with disability, with proportions by state ranging from 16.9% in Hawaii to 32.8% in New York. This proportion varied greatly by payer, with 38.1% for Medicare expenditures, 68.7% for Medicaid expenditures, and 12.5% for nonpublic health-care expenditures associated with disability.
As of 2002, 51.2 million Americans (18.1% of the U.S. civilian noninstitutionalized population) reported having a disability. 1 Among young adults, disability might result from a spinal cord injury, a congenital condition such as spina bifida, or a neurological disorder such as multiple sclerosis. Among older people, disability is often associated with the onset or worsening of chronic conditions, including arthritis, heart disease, diabetes, Alzheimer's disease, and cancer. Many people with disabilities, both young and old, experience secondary health problems as a result of their disabilities, including pain, pressure ulcers, obesity, and depression. 2 Consequently, people with disabilities are more likely than those without disabilities to report being in poor health. 1 Because of the detrimental effects that disabilities have on health, people with disabilities use more health-care services than people without disabilities, 3 resulting in higher health-care costs. These costs, which we define as disability-associated health-care expenditures (DAHE) , are in addition to a person's non-disability-related health-care expenditures. DAHE are the additional health-care costs related to injury, diseases, and chronic conditions associated with disability exclusive of those costs not related to disability. Although many people have chronic conditions, most do not have disabilities. Thus, this study attempted to separate the costs of non-disability-related assessment and treatment of injury, diseases, and chronic conditions from the incremental expenditures related to having a disability.
In a separate study, we estimated that U.S. DAHE approached $400 billion in 2006 (26.7% of national health-care spending for the year), with public payers bearing most of these costs (Unpublished data, Anderson WL, Wiener JM, Finkelstein EA, Armour BS. Estimates of national health-care expenditures associated with disability, 2009). In this study, we estimated DAHE at the state level and by public and private payers within each state. State-level estimates of DAHE are needed to inform federal efforts aimed at reducing disability prevalence and disability-associated health disparities. States will also be able to use these results when considering Medicaid access and funding initiatives for people with disabilities. The results of this study will provide policy makers and researchers with state-level estimates of DAHE and the relative fiscal burden these expenditures place on various payers.
METHODS

Data sources
We obtained data for this study from four sources. First, we used a definition of disability from the National Health Interview Survey (NHIS), sponsored by the National Center for Health Statistics. 4 Next, we used data from the Medical Expenditure Panel Survey (MEPS), a nationally representative survey derived in part from the NHIS and developed by the Agency for Healthcare Research and Quality, to develop an econometric model of health-care expenditures, sources of payment, and demographic and socioeconomic information on the civilian noninstitutionalized population. 5 Subsequently, we used state-level data from the Behavioral Risk Factor Surveillance System (BRFSS), 6 developed by the Centers for Disease Control and Prevention, with our linked NHIS/MEPS-based model to estimate the proportions of health-care expenditures associated with disability in each state and for each category of payer within each state. Finally, we used these proportions along with estimates of total health-care expenditures and expenditures by payer for each state from the National Health Expenditure Accounts (NHEA), which is maintained by the Centers for Medicare & Medicaid Services to generate estimates of total DAHE for each state and for each category of payer within each state. 7
Definition of disability
We considered NHIS respondents to have a disability if they responded "yes" to a question asking whether they had a limitation in any way in any activity because of a physical, mental, or emotional problem. This definition included all people reporting a disability of any type or severity. Examples of disability potentially reported include deficits in activities of daily living (ADL), such as bathing, eating, or toileting; instrumental activities of daily living (IADL), such as shopping and bill paying; and less permanent limitations, such as having a broken bone. Thus, it includes people with both long-and short-term disabilities.
Statistical analysis
We estimated DAHE in six steps. First, we estimated national DAHE for the noninstitutionalized population using a two-part model with Logit and a General Linear Model (GLM) and the linked NHIS/MEPS data. In our expenditure models, disability status was the policy variable of interest, and the models controlled for demographic and socioeconomic factors, category of payer, and national region. The dependent variable included Medicare, Medicaid, other public insurance, various types of private insurance, and uninsured expenditures.
Second, we predicted total annual health-care expenditures for each BRFSS individual by inputting BRFSS data values in the NHIS/MEPS Logit and GLM and reestimating the models. We also estimated the fraction of DAHE in each state and by payer within each state.
Third, we multiplied these fractions by NHEA estimates of total state-specific health-care expenditures to estimate DAHE for each state and by each payer within each state. This step was undertaken to account for expenditures missing from MEPS but included in the NHEA related to differences in service categories, the scope of the included populations, and nonpatient care revenues. 8 The steps to this point in our approach have been successfully applied in studies estimating state-level health-care expenditures for smoking [9] [10] [11] and obesity. 12, 13 Fourth, we combined these results with NHEA statelevel estimates of institutional (e.g., nursing home) DAHE to estimate total state DAHE. Fifth, we adjusted the BRFSS-based estimates of DAHE and payer distributions to a MEPS-based DAHE estimate and payer distribution from a prior RTI International study by the authors because of differences in the non-disability characteristics of the populations surveyed. Lastly, we calculated DAHE fractions of total expenditures by state. Complete methods used to estimate state-level DAHE are detailed in the Technical Appendix, which is available online (http://www.publichealthreports .org).
RESULTS
In 2006 We developed two maps of the United States to convey two different aspects of the magnitude and distribution of DAHE across the country in 2006. The first map (Figure 1 ), which presents DAHE per person with disability, can be used to analyze the extent to which each person with a disability adds further healthcare system expenditures and how those expenditures vary across states. The mean DAHE per person with a disability was $11,637 in the U.S. The highest cost per person with disability occurred in the District of Columbia (DC) ($22,494) , which was 2.9 times the lowest cost per person with a disability in Nevada ($7, 833) . Expenditures per person with a disability were less than $10,000 in 16 states, between $10,000 and $13,000 in 20 states, and more than $13,000 in 15 states. States with DAHE greater than $13,000 per person with a disability were primarily located in the Northeast and the noncontiguous U.S. Eleven of the 16 states with less than $10,000 per person with a disability were in the West or Mountain region.
The second map ( Figure 2 ) presents DAHE divided by the total population in a state, which can be used to identify differences in the societal costs of disability. The mean DAHE per capita was $2,190 in the U.S. In other words, the mean cost borne by each member of society, regardless of whether they have a disability, was $2,190. The highest per capita estimate was in DC ($3,360), which was 2.3 times the lowest per capita estimate in Utah ($1,443) . Per capita expenditures were less than $2,000 in 16 states, between $2,000 and $2,500 in 22 states, and more than $2,500 in 13 states. States with DAHE greater than $2,500 per capita were located primarily in the Northeast region and the western half of the Southeast region. Eleven of the 16 states with per capita DAHE less than $2,000 were in the West or Mountain region.
DISCUSSION
In 2006, DAHE accounted for $397.8 billion (26.7%) of all health-care expenditures for U.S. adults, which represents a substantial portion of U.S. health-care expenditures. In part, the magnitude of DAHE stems from the high disability prevalence in the adult population, with 18.2% of all adults reporting a limitation in any way in any activities because of physical, mental, or emotional problems. The NHIS-based definition of disability used in this study was broad and, therefore, included a large number of people, which contributed to the magnitude of DAHE. Even so, other definitions of disability, such as one used in a 2005 report 14 by the U.S. Surgeon General, provide even higher estimates (22.0%) of the proportion of the population with a disability. If we had chosen a narrower disability definition, such as having only any deficits with ADLs or IADLs, the prevalence of people with disabilities would be lower, although we would likely have captured the highest-cost people.
The disabilities included in our study definition varied in their duration, severity, and cause. Some disabilities, such as an inability to walk because of a broken foot, may be temporary and have low treatment costs, but are experienced more frequently than a permanent disability. Conversely, a permanent disability may more likely be accompanied by chronic conditions, with significantly higher treatment costs than a short-term disability. We were not able to assess the effects on DAHE of short-term vs. permanent disabilities because of the lack of relevant data, nor were we able to distinguish the cause of the reported disability. Both issues could be explored in future work.
The proportion of DAHE of 26.7% was higher than the prevalence of disability of 18.2% because people with disabilities use disproportionately more services than people without disabilities. 3 Even so, DAHE are relative to the health-care costs of all people with chronic conditions. Many more people have one or more chronic conditions or diseases than report disability, 15 and DAHE are smaller than the total cost of chronic conditions and diseases in the U.S. adult population.
The DAHE national estimate masks substantial variation across states, and across payers within states. This variation was associated with variations in the two factors that we multiplied to estimate DAHE for each state and payer within each state: (1) the proportion of all adult DAHE and (2) total adult health-care expenditures. The proportion of a state's total DAHE was associated with the relative distribution of costs across payers within states, with each payer having different proportions of DAHE. Generally, higher disability prevalence among Medicare and Medicaid beneficiaries in a state was positively associated with the proportion of DAHE. (Detailed information on disability prevalence across payers is available online in the Technical Appendix.) Variations in DAHE in the community population across states are driven by demographic differences, primarily age. States with a larger proportion of older people (e.g., Pennsylvania and West Virginia) are more likely to have higher disability prevalence and, therefore, higher DAHE. Conversely, state variation in DAHE per person living in an institution or per communitydwelling recipient of long-term-care services is driven by the generosity of the states' Medicaid programs.
The Medicaid program is not only the largest payer of DAHE among all payers nationally, but it is also the largest payer of DAHE in two-thirds of the states (33 of the 50 states plus DC) for two reasons. In 2007, Medicaid paid for the care of almost two-thirds (64.6%) of the 1.5 million Americans in nursing homes; 16 payments for this care accounted for 30.6% of all Medicaid DAHE. Second, Medicaid programs in states in the Northeast (e.g., New York) have particularly generous home-and community-based long-termcare programs. 17 In addition, while the difference in mean disability prevalence between the Medicaid and Medicare programs was less than 8 percentage points (46.3% vs. 39.0%), the proportion of DAHE was almost twice as high for Medicaid as for Medicare (68.7% vs. 38.1%) because of the high cost of institutional care paid by Medicaid. Therefore, the Medicaid program disproportionately bears the largest share of DAHE in the U.S.
Although DAHE per person with disability were similar for states in the West and Midwest regions, they varied more for states within the Northeast and Southeast regions, primarily because of greater stateto-state differences in disability prevalence and in the prevalence and cost of institutionalization. DAHE per capita were particularly high in the Northeast region (even though disability prevalence rates in Northeast states were generally below the national mean) and in the western half of the Southeast region. DC had the highest DAHE per capita and per person with disability in part because of the high rates paid to nursing homes. 18 New York, which had the second highest DAHE per capita and per person with disability, has by far the largest Medicaid personal care program in the U.S. 17 This study's findings demonstrate the need for interventions to prevent or delay disability. Some disability risk factors (e.g., falling, inactivity, and depression) can often be addressed through individual-level interventions. In a review of the literature on individual-level interventions, Freedman et al. found that in the short term, multicomponent fall-prevention interventions would likely have a greater effect on reducing the risk for disability than exercise or depression-treatment interventions alone. 19 These findings also provide a financial motivation to identify cost-effective strategies to effectively manage the treatment and costs of people with disabilities today. DAHE may be reduced by using preventive care services and health promotion interventions, and by improving access to medical care for people with disabilities to reduce the incidence of secondary conditions to disability through early diagnosis and intervention. For example, disease management programs may help maintain functional independence by preventing or delaying the onset of chronic conditions, resulting in decreased hospitalization and premature nursing home use. At a system level, programs to integrate Medicare and Medicaid payment through capitation for acute and long-term-care services (e.g., the Program of All-inclusive Care for the Elderly [PACE]) or pay-for-performance initiatives 20 might motivate providers to deliver high-quality care cost-effectively across targeted settings.
Limitations
This research had several limitations. First, because we lacked state-level data containing information on both disability prevalence and health-care expenditures, we had to use data from several sources to develop a synthetic estimate of state-level DAHE and, thus, were unable to calculate standard errors for our state-level estimates (see Technical Appendix).
The use of multiple data sources had several ramifications. To develop our DAHE estimate, we inferred that our NHIS/MEPS model estimates applied to the BRFSS population, even though the characteristics of people with disabilities differed between the two datasets. The BRFSS sample population with disabilities was considerably younger, much better educated, considerably less poor, and less likely to have Medicare and Medicaid than the NHIS/MEPS sample population with disabilities. In addition, we had to make predic-tions of BRFSS sample member insurance status using NHIS/MEPS estimates because the BRFSS sample lacked indicators of insurance status. Consequently, we adjusted our BRFSS DAHE estimate and payer distribution to the NHIS/MEPS DAHE estimate and payer distribution because the NHIS/MEPS population is more like the U.S. adult population.
Second, the DAHE estimate was large in part because we did not explicitly control for injuries and specific diseases and chronic conditions often associated with disability. Thus, some-but not all-of those costs were included in our estimate. Had we controlled for these additional health conditions, the DAHE estimate would have been smaller than reported. However, we used a standard econometric approach common in health services research to estimate the costs of single conditions or health problems. [9] [10] [11] [12] [13] Finally, both BRFSS and NHIS/MEPS rely on selfreported data, and responses can vary by survey administration mode. Recent work by Walsh and Khatutsky 21 has shown that in-person surveys underreport disability levels. In this study, while we used a common measure of disability from both surveys, the disability prevalence in the BRFSS (a telephone survey) was 18.2%, while the disability prevalence in the NHIS (an in-person survey) was 13.6%.
CONCLUSIONS
Results of this study indicated that state-level DAHE varied substantially in 2006 and that the costs of health care for people with disabilities are borne largely by the public sector, and particularly by Medicaid. Policy makers need to consider initiatives that will help reduce the prevalence of disabilities and disability-related health disparities, while also helping to improve the lives of people with disabilities. Knowing the amount and distribution of DAHE in 2006 will serve as a baseline for measuring improvements in access and reductions in disability prevalence resulting from future policy initiatives.
technical appendix
To quantify state-level health-care expenditures associated with disability, we first used a model that predicts national disability-associated health-care expenditures (DAHE). Next, we linked this model with state-level data to estimate DAHE for each state and payer within each state (Medicare, Medicaid, other public payers, private payers, and uninsured costs paid by individuals). We then adjusted these estimates to the National Health Expenditure Accounts (NHEA) developed by the Centers for Medicare & Medicaid Services (CMS). 1 Finally, we added state-level institutional expenditures and calculated the fraction of DAHE for each state.
MethOdS
Data
We used a measure of disability available from the 2001 and 2002 National Health Interview Survey (NHIS), 2 from which the 2002/2003 Medical Expenditure Panel Survey (MEPS) sampling frame 3 is drawn. In the NHIS, disability is defined as having a limitation in any way in any activity because of a physical, mental, or emotional problem. This definition includes all people reporting a deficit in activities of daily living (ADL), such as bathing, eating, or toileting; deficits in instrumental activities of daily living (IADL), such as shopping and bill paying; or short-term injuries or impairments.
The MEPS is a nationally representative survey of the civilian noninstitutionalized population developed by the Agency for Healthcare Research and Quality that collects data on total annual medical expenditures for each individual and by source of payment. We used MEPS data to identify individual annual health-care expenditures and all non-disability-related independent variables in our analysis. Annual expenditures included expenditures for inpatient, outpatient, prescription drug, emergency room, and home health-care services. Independent variables included demographic (age, gender, and race/ethnicity), socioeconomic (education, income, and marital status), geographic (U.S. Census regions), and payer (insurance) characteristics. The final MEPS sample contained 44,229 observations after removing 1,472 observations from the analytic file because of missing data, mostly because of missing information on IADL deficits.
We used data from the Behavioral Risk Factor Surveillance System (BRFSS) conducted by the Centers for Disease Control and Prevention to develop a nationally representative sample for estimating state-level DAHE.
The BRFSS is a state representative telephone survey of the adult noninstitutionalized population that tracks health risks in the United States. 4 We used five years of BRFSS data (2001, and 2003-2006, excluding 2002 for lack of disability data). We created independent variables similar to those we created in the MEPS for use in regressions. Our final BRFSS population contained 1,214,587 adults after removing 278,251 observations with missing data.
We adjusted our final state-level DAHE estimates to the NHEA, which are maintained by CMS and considered the gold standard for U.S. health-care expenditures. We used the NHEA 2003 State of Residence Files for estimates of total health-care expenditures by state, as well as for Medicare and Medicaid. These files contain institutional expenditures by state, which were added to our estimates of noninstitutional expenditures.
We estimated DAHE in six steps. First, we estimated national DAHE for the noninstitutionalized population using NHIS/MEPS data and made predictions of payer status for later use with BRFSS data, which lacked information on payers. Second, we input BRFSS data into the NHIS/MEPS model to estimate total and DAHE expenditures and calculated the fraction of DAHE in each state and by payer within each state. Third, we multiplied these fractions by NHEA state-specific health-care expenditures to estimate DAHE for each state and payer within each state. Fourth, we combined these results with institutional (e.g., nursing home) DAHE by state obtained from the NHEA to obtain total DAHE. Fifth, we adjusted the BRFSS-based DAHE estimate and payer distribution to a MEPS-based DAHE estimate and payer distribution previously developed by the authors. Sixth, we calculated fractions of DAHE by state.
First, we estimated national DAHE for the noninstitutionalized population using NHIS/MEPS data and a regression framework to account for differences in health-care expenditures by disability, demographic, socioeconomic, geographic, and payer characteristics. We used a method developed by Manning and Mullahy 5 to determine the regression model that best fit the distribution of the dependent variable-total healthcare expenditures. We found that a two-part model using Logit in the first part on all expenditures and a General Linear Model (GLM) with a gamma variance function and a log-link in the second part on only positive expenditures provided the best fit of the data.
We used the following specification for both parts of the model:
where disability is a dummy variable. Individuals were classified into one of seven unique insurance categories to preserve as much as possible the distribution of payer status we observed in the data. These categories were Medicare only, Medicaid only, both Medicare and Medicaid, private insurance (which also includes selfpaid insurance), both private insurance and Medicare, other insurance (e.g., other public insurance, workers' compensation insurance, and other types of specialty insurance, such as cancer insurance), and uninsured. Of the seven payer types, private insurance was the omitted group. We also included interactions of the disability variable with each payer category in all models to allow the marginal change in DAHE to vary by payer type. NHIS/MEPS regression estimates for Logit and GLM are shown in Tables 1 and 2. BRFSS does not collect information on payer types, so we developed a procedure using NHIS/MEPS to generate information on payer type for all BRFSS respondents. We began by estimating an NHIS/MEPSbased Multinomial Logit model to predict MEPS payer type as a function of all MEPS variables in the model previously mentioned, except those for payer type and the payer/disabled interactions. We also added to this regression model some additional MEPS explanatory variables for employment and health status to better account for individual variation in payer status. After running the model, we predicted the point prevalence of having each payer type in MEPS data by calculating the mean individual predicted probabilities for each payer type. For example, to estimate the point prevalence in the sample of having Medicare only, we found the mean of individual predicted Medicare probabilities. We found a close association between MEPS actual and predicted payer type using this approach (Table 3) . Subsequently, we calculated the predicted payer probabilities for each BRFSS person using the MEPS Multinomial Logit coefficients and BRFSS data and used these probabilities as indicators of payer type for BRFSS people in subsequent steps.
Second, we input BRFSS data into the NHIS/MEPS regression models to estimate total expenditures and DAHE and calculate the fraction of DAHE in each state and by payer within each state. We began this process by predicting total annual health-care expenditures for each BRFSS individual using the two-part model by inputting BRFSS data values in the NHIS/MEPS Logit and GLM. Table 4 shows the prevalence of disability in BRFSS data by state and payer within each state. Prevalence of disability in BRFSS data was 18.2% in the U.S., 39.0% in the Medicare population, 46.3% among Medicaid recipients, 14.6% among people with private insurance, 25.8% for people with other insurance, Table 5 shows the unweighted means for BRFSS data by disability status across states. People reporting a disability were more likely than people not reporting a disability to be older, female, white, and unmarried; live in the Southeast; have less education and income; and to have publicly sponsored insurance. We then multiplied the predicted values for each respondent from each part of the two-part model to obtain predicted total annual expenditures for each BRFSS participant. We then applied the BRFSS weights to obtain total predicted annual expenditures for each state. We also used the same regression model with BRFSS data to calculate individual DAHE as the difference between predicted expenditures using actual BRFSS data values and predicted expenditures with the disability dummy variable switched to 0 (as well as the interaction terms between disability and payer type), leaving all other variables unchanged. We also used the weights to estimate state DAHE.
After model estimation, to correctly attribute expenditures to single payer categories, we assigned the expenditures for people with more than one payer (e.g., Medicare and Medicaid, and Medicare and private insurance) to their respective individual payer categories using the mean payer distribution of expenditures in the MEPS data. For example, Medicare/Medicaid dual eligibles had a mean of 53.3% of their expenditures paid by Medicare, with the remainder paid by Medicaid, and people with Medicare and private insurance had a mean of 62.4% of their expenditures paid by Medicare, with the remainder paid by private insurance. We calculated these percentages for both the total predicted medical expenditures and DAHE by state. (Table 6 ). We assumed that NHEA total Medicare expenditures were exclusively for adults. We calculated adult total Medicaid expenditures as 78.1% of total NHEA Medicaid expenditures using age-specific expenditure data available from the 1999 Medicaid Statistical Information System. 6 We assumed this proportion did not change between 1999 and 2003. Fourth, we obtained estimates of total DAHE by state and payer within state by combining estimates of NHEA expenditures for people in institutions with noninstitutional DAHE from Step 3. Though people in institutions have a disability, not all health-care expenditures for these people are appropriately classified as DAHE, as some small proportion are acute care expenditures (e.g., emergent and non-disability-related surgery). We assumed 87.5% of institutional expenditures for all payers were DAHE using adjustments to data on noninstitutional acute care expenditures for people in institutions. 7 Fifth, we adjusted the BRFSS-based DAHE estimate and associated payer distribution to an NHIS/MEPSbased DAHE estimate and payer distribution that had been previously reconciled with the NHEA. While our national BRFSS DAHE estimate was within 2% of our prior national NHIS/MEPS DAHE estimate of $397.9 billion for 2006, the distribution of DAHE by payer differed across the two surveys because of differences in the non-disability characteristics of the populations surveyed. Our BRFSS sample population with disabilities was considerably younger, much better educated, considerably less poor, and less likely to have Medicare and Medicaid than the NHIS/MEPS sample population with disabilities ( Table 7) . Much of this difference may be attributable to differences in the survey mode. NHIS/MEPS data are obtained through an in-person interview, and BRFSS data are obtained by phone, so BRFSS misses the population without telephones, which may be disproportionately poorer and with higher receipt of Medicaid.
Given that we had previously adjusted our national MEPS DAHE estimate to the NHEA (Unpublished data, Anderson WL, Wiener JM, Finkelstein EA, Armour BS. Estimates of national health-care expenditures associated with disability, 2009), we directly adjusted our national BRFSS DAHE estimate and payer distribution to the national MEPS DAHE estimate and payer distribution to eliminate the differences in the survey populations. This resulted in slightly more than one-third increases in BRFSS Medicare and Medicaid DAHE, slightly more than two-thirds decreases in BRFSS DAHE for the uninsured and people with other insurance, and an approximate 40% reduction in BRFSS private insurance DAHE (Table 8 ). We then inflated these adjusted expenditure estimates from 2003 to 2006 dollars using the Consumer Price Index Medical Care Component.
Sixth, we calculated the fraction of DAHE for each state and payer within each state by dividing DAHE by corresponding total expenditures.
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